Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Rathan M. Subramaniam"'
Publikováno v:
Nuclear medicine communications. 42(8)
Objective To establish the detection rate of prostate cancer recurrence following definitive therapy by 18F-fluciclovine PET/computed tomography (CT) in patients with biochemical recurrence (BCR) and prostate-specific antigen (PSA) levels less than 2
Publikováno v:
Clinical Nuclear Medicine. 43:710-714
Objective To evaluate the value of I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (I-FP-CIT) dopamine transporter single photon emission computed tomography (DAT-SPECT) to change management strategies of patients suspected of par
Autor:
Se J. Ahn, Sara Sheikhbahaei, Rathan M. Subramaniam, Charles Marcus, Mehdi Taghipour, Brenda Young
Publikováno v:
Nuclear Medicine Communications. 38:720-725
This study aimed to evaluate the comparative effectiveness of follow-up fluorine-18-fluorodeoxyglucose (F-FDG)-PET/CT and chest CT in the detection of local, regional, and distant metastatic diseases in lung cancer.Follow-up F-FDG-PET/CT and chest-CT
Autor:
Tyler J. Trahan, Rathan M. Subramaniam, Rutuparna Sarangi, Mehdi Taghipour, Shani Jones, Charles Marcus
Publikováno v:
Nuclear Medicine Communications. 37:699-704
To evaluate the impact of fourth and subsequent follow-up PET/computed tomography (PET/CT) scans in patients with non-Hodgkins lymphoma (NHL).This retrospective study evaluated all biopsy-proven NHL patients who had more than three follow-up scans af
Publikováno v:
Nuclear Medicine Communications. 37:602-608
To evaluate the accuracy and value of the fourth and subsequent post-therapy follow-up fluorine-18 fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) scans in the clinical assessment of breast cancer patients.Ninety-two female patients, with a t
Publikováno v:
American Journal of Roentgenology. 206:846-855
The objective of this study was to assess the value of quantitative PET parameters in the prediction of survival for patients with recurrent breast cancer.We conducted a retrospective study of 78 women who had recurrent breast cancer identified by bi
Autor:
Christine H. Chung, Justin A. Bishop, Carole Fakhry, Nishant Agrawal, Joseph A. Califano, Jesse R Qualliotine, Rathan M. Subramaniam, David W. Eisele, Wayne M. Koch, Zhe Zhang, Raphael P. Viscidi, Daria A. Gaykalova
Publikováno v:
Cancer Prevention Research. 9:135-141
Human papillomavirus (HPV) is responsible for increasing incidence of oropharyngeal cancer. At present, there are no biomarkers in the surveillance algorithm for HPV-positive oropharyngeal cancer (HPV-OPC). HPV16 E6 antibody precedes oropharyngeal ca
Publikováno v:
Journal of Nuclear Medicine. 56:989-994
The purpose of this study was to evaluate the added value of a fourth and subsequent follow-up PET/CT scans to clinical assessment and impact on patient management in patients with colorectal cancer. Methods: This was an institutional review board–
Autor:
Richard L. Wahl, Timothy M. Pawlik, Krishna Alluri, Joseph M. Herman, Alin Chirindel, Muhammad A. Chaudhry, Rathan M. Subramaniam
Publikováno v:
American Journal of Roentgenology. 204:1093-1099
The purpose of this study is to evaluate the performance of PET-derived parameters as prognostic markers for overall survival (OS) and progression-free survival (PFS) outcome in patients with pancreatic adenocarcinoma.We conducted a retrospective stu
Publikováno v:
PET Clinics. 10:125-145
There is a growing body of evidence that point to the value of 18F fluoro-deoxyglucose-PET/CT in the management of head and neck cancer (HNC) patients and predicting patient-related outcomes. FDG-PET/CT changes the baseline staging (compared with CT